Abstract Supplementary Table S1 Continuous Glucose Monitoring (CGM) has been
demonstrated to be clinically valuable, reducing risks of hypoglycemia and hyperglycemia …

Glucose management in intensive care unit (ICU) patients has been a matter of debate for
almost two decades. Compared to intermittent monitoring systems, continuous glucose …

Abstract «Variability in glucose homoeostasis» is a better description than «glycaemic
variability» as it encompasses two categories of dysglycaemic disorders: i) the short-term …

Background High glycemic variability (GV) is common in critically ill patients; however, the
prevalence and mortality association with early GV in patients with sepsis remains unclear …

In June 2016, Diabetes Technology Society convened a panel of US experts in inpatient
diabetes management to discuss the current and potential role of continuous glucose …

The ideal blood glucose target remains unclear and may depend on the context. As
compared with tolerating severe hyperglycemia, tight glucose control is well tolerated and …

Over the past decade, there has been an unprecedented international focus on improved
quality and availability of medical care, which has reignited interest in clinical automation …

For years, the standard-of-care for monitoring dysglycemia in hospitalized patients was
capillary blood glucose (CBG) testing with point-of-care glucose meters. Recently, there has …

Diabetes is one of the most common comorbidities in hospitalized patients with coronavirus
disease 2019 (COVID-19). Inpatient hyperglycemia during this pandemic has been …

Phagocytes are cells of the immune system that play important roles in phagocytosis,
respiratory burst and degranulation—key components of innate immunity and response to …